RTI Surgical Inc. (NASDAQ:RTIX)’s share price traded down 2.4% on Wednesday . The company traded as low as $3.71 and last traded at $3.73, with a volume of 63,809 shares traded. The stock had previously closed at $3.82.

Separately, Zacks Investment Research raised RTI Surgical from a “hold” rating to a “strong-buy” rating and set a $4.75 price target on the stock in a research report on Wednesday, April 20th.

The stock has a market cap of $217.20 million and a P/E ratio of 21.24. The company’s 50-day moving average is $3.74 and its 200-day moving average is $3.71.

RTI Surgical (NASDAQ:RTIX) last released its quarterly earnings data on Thursday, April 28th. The company reported $0.03 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.03. The company had revenue of $67.40 million for the quarter, compared to the consensus estimate of $65.68 million. RTI Surgical’s revenue for the quarter was down .9% compared to the same quarter last year. During the same period last year, the company earned $0.05 EPS. On average, analysts expect that RTI Surgical Inc. will post $0.19 EPS for the current fiscal year.

Several institutional investors recently added to or reduced their stakes in RTIX. Dimensional Fund Advisors LP boosted its position in RTI Surgical by 1.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,595,287 shares of the company’s stock worth $14,273,000 after buying an additional 44,725 shares during the period. LSV Asset Management bought a new position in RTI Surgical during the fourth quarter worth about $1,432,000. Royce & Associates LLC boosted its position in RTI Surgical by 30.9% in the fourth quarter. Royce & Associates LLC now owns 1,558,774 shares of the company’s stock worth $6,188,000 after buying an additional 368,000 shares during the period. Finally, Paradigm Capital Management Inc. NY boosted its position in RTI Surgical by 17.4% in the fourth quarter. Paradigm Capital Management Inc. NY now owns 4,438,200 shares of the company’s stock worth $17,620,000 after buying an additional 658,474 shares during the period.

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.